nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—osteoarthritis	0.465	0.603	CbGaD
Captopril—MMP9—osteoarthritis	0.306	0.397	CbGaD
Captopril—MMP9—synovial fluid—osteoarthritis	0.0115	0.127	CbGeAlD
Captopril—F2—knee—osteoarthritis	0.00908	0.0999	CbGeAlD
Captopril—MMP2—skeletal joint—osteoarthritis	0.00858	0.0944	CbGeAlD
Captopril—MMP9—skeletal joint—osteoarthritis	0.00747	0.0821	CbGeAlD
Captopril—MMP2—hindlimb—osteoarthritis	0.00586	0.0645	CbGeAlD
Captopril—MMP2—cartilage tissue—osteoarthritis	0.00577	0.0635	CbGeAlD
Captopril—F2—vertebral column—osteoarthritis	0.00518	0.0569	CbGeAlD
Captopril—MMP9—hindlimb—osteoarthritis	0.0051	0.0561	CbGeAlD
Captopril—MMP9—cartilage tissue—osteoarthritis	0.00502	0.0552	CbGeAlD
Captopril—F2—leg—osteoarthritis	0.00498	0.0548	CbGeAlD
Captopril—F2—forelimb—osteoarthritis	0.00494	0.0544	CbGeAlD
Captopril—F2—hindlimb—osteoarthritis	0.00445	0.0489	CbGeAlD
Captopril—ACE—skeletal joint—osteoarthritis	0.00398	0.0438	CbGeAlD
Captopril—ACE—forelimb—osteoarthritis	0.00302	0.0332	CbGeAlD
Captopril—ACE—hindlimb—osteoarthritis	0.00272	0.0299	CbGeAlD
Captopril—LTA4H—tendon—osteoarthritis	0.00139	0.0153	CbGeAlD
Captopril—MMP2—tendon—osteoarthritis	0.000987	0.0108	CbGeAlD
Captopril—MMP9—tendon—osteoarthritis	0.000858	0.00944	CbGeAlD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoarthritis	0.000222	0.00161	CbGpPWpGaD
Captopril—MMP9—Matrix Metalloproteinases—TNF—osteoarthritis	0.00022	0.00159	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.000219	0.00158	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—COL9A2—osteoarthritis	0.000216	0.00156	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—IGF1—osteoarthritis	0.000214	0.00154	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ADAMTS5—osteoarthritis	0.000213	0.00154	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ADAMTS3—osteoarthritis	0.000213	0.00154	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TIMP1—osteoarthritis	0.000211	0.00152	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—COL9A1—osteoarthritis	0.000209	0.00151	CbGpPWpGaD
Captopril—F2—Syndecan-4-mediated signaling events—MMP9—osteoarthritis	0.000209	0.00151	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—HSPA5—osteoarthritis	0.000209	0.00151	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—TNF—osteoarthritis	0.000209	0.00151	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—MMP2—osteoarthritis	0.000207	0.00149	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000206	0.00148	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ADAMTS13—osteoarthritis	0.000204	0.00147	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MMP2—osteoarthritis	0.000202	0.00146	CbGpPWpGaD
Captopril—F2—Folate Metabolism—CRP—osteoarthritis	0.000199	0.00144	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—BGN—osteoarthritis	0.000199	0.00143	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—osteoarthritis	0.000198	0.00143	CbGpPWpGaD
Captopril—MMP9—Axon guidance—COL9A2—osteoarthritis	0.000198	0.00143	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—osteoarthritis	0.000195	0.00141	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—TGFB1—osteoarthritis	0.000195	0.00141	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL1A—osteoarthritis	0.000194	0.0014	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—ADAMTS4—osteoarthritis	0.000193	0.0014	CbGpPWpGaD
Captopril—MMP9—Axon guidance—COL9A1—osteoarthritis	0.000192	0.00139	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ADAMTS3—osteoarthritis	0.000192	0.00138	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ADAMTS5—osteoarthritis	0.000192	0.00138	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL2A1—osteoarthritis	0.000189	0.00137	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GSTO1—osteoarthritis	0.000183	0.00132	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CTSK—osteoarthritis	0.000183	0.00132	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.000182	0.00132	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—ADAMTS4—osteoarthritis	0.000181	0.00131	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—osteoarthritis	0.00018	0.0013	CbGpPWpGaD
Captopril—LTA4H—Metabolism—BGN—osteoarthritis	0.000177	0.00128	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—MMP9—osteoarthritis	0.000174	0.00126	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—osteoarthritis	0.000173	0.00125	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—CXCL8—osteoarthritis	0.000172	0.00124	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—IL6—osteoarthritis	0.000168	0.00121	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—osteoarthritis	0.000168	0.00121	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP3—osteoarthritis	0.000164	0.00119	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—IHH—osteoarthritis	0.000163	0.00118	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ADAMTS4—osteoarthritis	0.000163	0.00118	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP13—osteoarthritis	0.000161	0.00116	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CXCL8—osteoarthritis	0.00016	0.00116	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000159	0.00115	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—LEP—osteoarthritis	0.000159	0.00115	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000158	0.00114	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—IL6—osteoarthritis	0.000157	0.00114	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—BMP2—osteoarthritis	0.000155	0.00112	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.000153	0.0011	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—MMP2—osteoarthritis	0.000152	0.0011	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoarthritis	0.00015	0.00108	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—MMP1—osteoarthritis	0.000146	0.00105	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.000144	0.00104	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—COL9A2—osteoarthritis	0.000141	0.00102	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TIMP1—osteoarthritis	0.000139	0.001	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—COL9A1—osteoarthritis	0.000137	0.000992	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000135	0.000977	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—FN1—osteoarthritis	0.000133	0.00096	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP1—osteoarthritis	0.000131	0.000948	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000129	0.000935	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—TGFB1—osteoarthritis	0.000128	0.000926	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL1B—osteoarthritis	0.000124	0.000898	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—MMP1—osteoarthritis	0.000124	0.000892	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000123	0.00089	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—FN1—osteoarthritis	0.00012	0.000865	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—LEP—osteoarthritis	0.00012	0.000863	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TGFB1—osteoarthritis	0.000119	0.000862	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—HSPA5—osteoarthritis	0.000116	0.000836	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ADAMTS13—osteoarthritis	0.000115	0.000829	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000114	0.000826	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoarthritis	0.000113	0.000813	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000111	0.000801	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.00011	0.000796	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.00011	0.000796	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—PTGS2—osteoarthritis	0.000109	0.000785	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ADAMTS5—osteoarthritis	0.000108	0.00078	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ADAMTS3—osteoarthritis	0.000108	0.00078	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP3—osteoarthritis	0.000108	0.000778	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000106	0.000767	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CXCL8—osteoarthritis	0.000105	0.000761	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.000105	0.000759	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—HSPA5—osteoarthritis	0.000104	0.000748	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL1B—osteoarthritis	0.000101	0.00073	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—IGF1—osteoarthritis	9.88e-05	0.000713	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL1B—osteoarthritis	9.88e-05	0.000713	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	9.8e-05	0.000708	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	9.72e-05	0.000702	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FN1—osteoarthritis	9.59e-05	0.000692	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—MMP2—osteoarthritis	9.56e-05	0.00069	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—HSPA5—osteoarthritis	9.32e-05	0.000673	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—MCF2L—osteoarthritis	9.23e-05	0.000666	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ADAMTS4—osteoarthritis	9.18e-05	0.000663	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TNF—osteoarthritis	9.02e-05	0.000651	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—SMAD3—osteoarthritis	9e-05	0.00065	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL6—osteoarthritis	9e-05	0.00065	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IL6—osteoarthritis	8.95e-05	0.000646	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP1—osteoarthritis	8.61e-05	0.000622	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IHH—osteoarthritis	8.38e-05	0.000605	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MCF2L—osteoarthritis	8.38e-05	0.000605	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CXCL8—osteoarthritis	7.94e-05	0.000574	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	7.93e-05	0.000573	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—CRP—osteoarthritis	7.91e-05	0.000571	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TGFB1—osteoarthritis	7.86e-05	0.000568	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—FN1—osteoarthritis	7.86e-05	0.000567	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—LEP—osteoarthritis	7.7e-05	0.000556	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—MMP9—osteoarthritis	7.64e-05	0.000551	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TNF—osteoarthritis	7.34e-05	0.00053	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	7.31e-05	0.000528	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL6—osteoarthritis	7.28e-05	0.000526	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	7.21e-05	0.00052	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1A—osteoarthritis	7.18e-05	0.000518	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—TNF—osteoarthritis	7.17e-05	0.000517	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—FN1—osteoarthritis	6.99e-05	0.000505	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	6.78e-05	0.00049	CbGpPWpGaD
Captopril—F2—Hemostasis—HSPA5—osteoarthritis	6.67e-05	0.000482	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP2—osteoarthritis	6.66e-05	0.000481	CbGpPWpGaD
Captopril—MMP2—Axon guidance—MMP9—osteoarthritis	6.48e-05	0.000468	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MCF2L—osteoarthritis	6.41e-05	0.000463	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IHH—osteoarthritis	6.41e-05	0.000463	CbGpPWpGaD
Captopril—F2—Hemostasis—TIMP1—osteoarthritis	6.36e-05	0.000459	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—TGFB1—osteoarthritis	6.29e-05	0.000454	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	6.28e-05	0.000454	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—FN1—osteoarthritis	6.26e-05	0.000452	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—MMP1—osteoarthritis	6.14e-05	0.000443	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	6.13e-05	0.000443	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	6.06e-05	0.000438	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	5.96e-05	0.00043	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—LEP—osteoarthritis	5.94e-05	0.000429	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL6—osteoarthritis	5.92e-05	0.000428	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SMAD3—osteoarthritis	5.91e-05	0.000426	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—osteoarthritis	5.78e-05	0.000418	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MMP2—osteoarthritis	5.66e-05	0.000408	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—osteoarthritis	5.56e-05	0.000402	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP1—osteoarthritis	5.52e-05	0.000398	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—IGF1—osteoarthritis	5.48e-05	0.000396	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—LEP—osteoarthritis	5.34e-05	0.000386	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—HSPA5—osteoarthritis	5.25e-05	0.000379	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	5.22e-05	0.000377	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—osteoarthritis	5.14e-05	0.000371	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	5.14e-05	0.000371	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—osteoarthritis	5.1e-05	0.000368	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—LEP—osteoarthritis	5.05e-05	0.000364	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MCF2L—osteoarthritis	4.95e-05	0.000357	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IHH—osteoarthritis	4.95e-05	0.000357	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL1B—osteoarthritis	4.93e-05	0.000356	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—IGF1—osteoarthritis	4.91e-05	0.000354	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	4.89e-05	0.000353	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	4.82e-05	0.000348	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—COL9A2—osteoarthritis	4.71e-05	0.00034	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MMP9—osteoarthritis	4.63e-05	0.000334	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—COL9A1—osteoarthritis	4.57e-05	0.00033	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—IGF1—osteoarthritis	4.41e-05	0.000319	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	4.4e-05	0.000318	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—MMP2—osteoarthritis	4.27e-05	0.000308	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	4.21e-05	0.000304	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—TGFB1—osteoarthritis	4.13e-05	0.000298	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MMP2—osteoarthritis	4.04e-05	0.000291	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—osteoarthritis	4.03e-05	0.000291	CbGpPWpGaD
Captopril—F2—Hemostasis—MMP1—osteoarthritis	3.95e-05	0.000285	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—osteoarthritis	3.95e-05	0.000285	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	3.92e-05	0.000283	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	3.9e-05	0.000282	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TGFB1—osteoarthritis	3.81e-05	0.000275	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL1B—osteoarthritis	3.74e-05	0.00027	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	3.73e-05	0.000269	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	3.67e-05	0.000265	CbGpPWpGaD
Captopril—F2—Signaling Pathways—COL9A2—osteoarthritis	3.63e-05	0.000262	CbGpPWpGaD
Captopril—F2—Hemostasis—FN1—osteoarthritis	3.61e-05	0.00026	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—osteoarthritis	3.58e-05	0.000258	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—osteoarthritis	3.56e-05	0.000257	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	3.55e-05	0.000256	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—osteoarthritis	3.55e-05	0.000256	CbGpPWpGaD
Captopril—F2—Signaling Pathways—COL9A1—osteoarthritis	3.53e-05	0.000255	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—TGFB1—osteoarthritis	3.29e-05	0.000237	CbGpPWpGaD
Captopril—F2—Hemostasis—IGF1—osteoarthritis	3.16e-05	0.000228	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	3.13e-05	0.000226	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BMP2—osteoarthritis	3.13e-05	0.000226	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP1—osteoarthritis	3.11e-05	0.000224	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—LEP—osteoarthritis	3.01e-05	0.000217	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	2.91e-05	0.00021	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—osteoarthritis	2.89e-05	0.000209	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—osteoarthritis	2.87e-05	0.000207	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	2.84e-05	0.000205	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—osteoarthritis	2.84e-05	0.000205	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MMP3—osteoarthritis	2.84e-05	0.000205	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	2.83e-05	0.000204	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	2.78e-05	0.0002	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	2.77e-05	0.0002	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—osteoarthritis	2.72e-05	0.000196	CbGpPWpGaD
Captopril—ALB—Hemostasis—HSPA5—osteoarthritis	2.65e-05	0.000191	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—osteoarthritis	2.64e-05	0.000191	CbGpPWpGaD
Captopril—ALB—Metabolism—FMOD—osteoarthritis	2.64e-05	0.00019	CbGpPWpGaD
Captopril—ALB—Hemostasis—TIMP1—osteoarthritis	2.52e-05	0.000182	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—osteoarthritis	2.5e-05	0.000181	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF1—osteoarthritis	2.49e-05	0.000179	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	2.43e-05	0.000176	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BMP2—osteoarthritis	2.42e-05	0.000175	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—osteoarthritis	2.41e-05	0.000174	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	2.39e-05	0.000173	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—osteoarthritis	2.34e-05	0.000169	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FMOD—osteoarthritis	2.31e-05	0.000167	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	2.29e-05	0.000166	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FMOD—osteoarthritis	2.18e-05	0.000157	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MMP3—osteoarthritis	2.17e-05	0.000157	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGES—osteoarthritis	2.15e-05	0.000155	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—osteoarthritis	2e-05	0.000144	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	1.99e-05	0.000143	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD3—osteoarthritis	1.96e-05	0.000142	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—osteoarthritis	1.89e-05	0.000137	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—osteoarthritis	1.88e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGES—osteoarthritis	1.88e-05	0.000136	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGES—osteoarthritis	1.77e-05	0.000128	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LEP—osteoarthritis	1.68e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP3—osteoarthritis	1.68e-05	0.000121	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—osteoarthritis	1.61e-05	0.000116	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—osteoarthritis	1.6e-05	0.000116	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FN1—osteoarthritis	1.58e-05	0.000114	CbGpPWpGaD
Captopril—ALB—Hemostasis—MMP1—osteoarthritis	1.57e-05	0.000113	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD3—osteoarthritis	1.52e-05	0.000109	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTO1—osteoarthritis	1.51e-05	0.000109	CbGpPWpGaD
Captopril—ALB—Metabolism—BGN—osteoarthritis	1.47e-05	0.000106	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—osteoarthritis	1.46e-05	0.000105	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	1.46e-05	0.000105	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	1.44e-05	0.000104	CbGpPWpGaD
Captopril—ALB—Hemostasis—FN1—osteoarthritis	1.43e-05	0.000103	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—osteoarthritis	1.39e-05	0.0001	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	1.34e-05	9.68e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTO1—osteoarthritis	1.33e-05	9.58e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—osteoarthritis	1.3e-05	9.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BGN—osteoarthritis	1.28e-05	9.27e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—osteoarthritis	1.25e-05	9.05e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTO1—osteoarthritis	1.25e-05	9.02e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—osteoarthritis	1.24e-05	8.93e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FN1—osteoarthritis	1.22e-05	8.83e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BGN—osteoarthritis	1.21e-05	8.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—osteoarthritis	1.12e-05	8.05e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—osteoarthritis	1.07e-05	7.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	9.46e-06	6.83e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—osteoarthritis	8.61e-06	6.22e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—osteoarthritis	8.32e-06	6e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—osteoarthritis	8.19e-06	5.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—osteoarthritis	7.79e-06	5.62e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—osteoarthritis	7.52e-06	5.43e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—osteoarthritis	6.42e-06	4.64e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—osteoarthritis	6.27e-06	4.52e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—osteoarthritis	4.84e-06	3.49e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—osteoarthritis	4.21e-06	3.04e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—osteoarthritis	3.69e-06	2.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—osteoarthritis	3.48e-06	2.51e-05	CbGpPWpGaD
